Key result
Low-dose UFH is linked to better survival and less ICH vs standard-dose in ECMO patients.
Why the study?
Controversies exist in anticoagulation practices during ECMO, and it is uncertain whether the intensity of anticoagulation affects clinical outcomes.
Does low-dose unfractionated heparin anticoagulation reduce short-term mortality in patients on ECMO compared to standard-dose?
Meta-Analysis
Does low-dose unfractionated heparin anticoagulation reduce short-term mortality in patients on ECMO compared to standard-dose?
Low-dose unfractionated heparin may be a safer and more effective anticoagulation strategy than standard-dose for patients on ECMO, improving survival and reducing intracranial hemorrhage.
Answers are grounded in this paper and cite their sources.
Low-intensity anticoagulation may reduce bleeding in ECMO without excess thrombosis; extends observational data but leaves randomized confirmation open.
Background: Controversies exist in anticoagulation practices in extracorporeal membrane oxygenation (ECMO). It is uncertain whether the intensity of anticoagulation affects ECMO outcomes. Objectives: To conduct a meta-analysis to determine whether anticoagulation intensity affects ECMO outcomes. Methods: The Medical Literature Analysis and Retrieval System Online, Embase, and Central Register of Controlled Trials' databases were searched from inception to October 2024 for trials comparing the use of low-dose (LD) and standard-dose unfractionated heparin anticoagulation in patients on ECMO. The primary outcome was short-term mortality. Secondary outcomes included major bleeding events, intracranial hemorrhage (ICH), oxygenator changes, systemic thrombotic events, and ECMO duration. Data were pooled using a random-effects meta-analysis. The risk-of-bias was assessed using the Cochrane Risk-of-Bias 2 tool for randomized controlled trials and the Risk-of-Bias in Non-Randomized Studies of Interventions for nonrandomized controlled trials. Conclusion: This meta-analysis suggests that LD unfractionated heparin anticoagulation is associated with significantly better survival and a lower risk of ICH without an increase in the risk of thrombotic events. LD anticoagulation should be considered a reasonable strategy in ECMO.
No takes yet. Share an insight, caveat, or question.
Ng et al. (2025) conducted a meta-analysis in Extracorporeal membrane oxygenation (ECMO). Low-dose unfractionated heparin vs. Standard-dose unfractionated heparin was evaluated on Short-term mortality. Low-dose unfractionated heparin anticoagulation was associated with significantly better survival and a lower risk of intracranial hemorrhage compared to standard-dose in patients on ECMO.
Synapse has enriched 10 related papers. Consider them for comparative context: